Compare GNTA & ZSTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNTA | ZSTK |
|---|---|---|
| Founded | 2014 | 2019 |
| Country | Italy | Canada |
| Employees | 13 | 76 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9M | 20.0M |
| IPO Year | N/A | N/A |
| Metric | GNTA | ZSTK |
|---|---|---|
| Price | $0.63 | $8.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 60.6K | 10.8K |
| Earning Date | 03-24-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $15.73 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.61 | $6.31 |
| 52 Week High | $10.00 | $11.00 |
| Indicator | GNTA | ZSTK |
|---|---|---|
| Relative Strength Index (RSI) | 25.64 | 49.88 |
| Support Level | N/A | $7.78 |
| Resistance Level | $1.70 | $9.33 |
| Average True Range (ATR) | 0.08 | 0.60 |
| MACD | -0.02 | 0.10 |
| Stochastic Oscillator | 8.95 | 54.99 |
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
ZeroStack Corp is an AI focused asset management company. The company also operates a world-wide pharmaceutical distribution business through its wholly owned subsidiary. ZeroStack is focused on providing exposure to decentralized AI through a concentrated digital asset approach structured to generate yield and fee-based income from staking validators, compute power technology companies, and complementary businesses within the ecosystem and across the wider AI landscape.